• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • News & Insights
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE News & Insights (Formerly CBE Week)
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE News & Insights (Formerly CBE Week)
    • CBE Policy and Legal
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • PR Newswire
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / Hemp Business Executive / Hemp Policy & Legal / Synthetic vs. Natural Hemp: A Legal and Labeling Minefield

Synthetic vs. Natural Hemp: A Legal and Labeling Minefield

November 11, 2020 by Henry Baskerville Leave a Comment

The DEA’s recent interim final rule–which appears to be in contravention of the letter and spirit of the Agricultural Improvement Act of 2018 (aka the Farm Bill)–continues to cause concern and turmoil in the industry.

The proposed rule addresses CBD and hemp manufacturing, and threatens to criminalize certain hemp derived cannabinoids, extracts and derivatives, and received over 3,300 comments during the public comment period. 

New Rule Generates Lawsuits, Letters from Congress and a Need for Clarity

Additionally, the Hemp Industries Association (HIA), along with a South Carolina-based hemp company, filed suit against the U.S. Drug Enforcement Administration (DEA) not once, but twice. Nine members of Congress sent a letter to the DEA’s Acting Administrator voicing the concerns of their hemp constituents, who now fear unknowingly producing or possessing a controlled substance, violating the law and potentially putting themselves out of business.

The cannabis industry needs clarity on what is and what is not legal.  In order to toe the line, hemp farmers, processors and cannabis businesses must have an understanding of where that line is. To the extent that the DEA was trying to resolve confusion with its interim rule, I applaud it. But it should be obvious by now that the interim rule has resulted in more, not less, confusion. 

 Delta-8 and the Debate over Synthetic vs. Natural Cannabinoids

I recently wrote about the interim rule’s potential legal impact on Delta-8 THC, a tetrahydrocannabinol derived from hemp, sharing my legal opinion as an attorney who regularly helps cannabis clients ensure compliance with the law. Delta-8 THC may be at risk of possibly being labeled a Schedule I Narcotic by the DEA due to its potential classification as a “synthetically derived tetrahydrocannabinol”, a murky, ill-defined delineation that is creating bewilderment in the industry. 

Currently, most of the Delta-8 THC on the market is derived from CBD isolate via a chemical process. This is because extraction directly from hemp does not generally elicit high enough concentrations or quantities to make it a profitable option. As a result, some might say Delta-8 THC is extracted from isolate, some might say it is converted. The real question is whether that chemical extraction process—from a product that itself was naturally derived and extracted from hemp (i.e., isolate)—makes Delta-8 a synthetic cannabinoid. I say no. 

Nearly all CBD is extracted from hemp using chemicals (often ethanol) but that doesn’t mean that CBD is synthetic. And many CBD products are the result of numerous rounds of extraction—first from hemp to crude, then to distillate and sometimes to isolate. Adding an extra step to the refining process doesn’t make something natural suddenly become synthetic. If it did, then the proposed rule would abrogate the entire Farm Bill and make virtually all CBD a Schedule 1 Narcotic, something that is well beyond the DEA’s purview. The DEA is a law enforcement agency. It does not write the laws themselves.  

Transparent Labeling

That said, there are truly synthetic cannabinoids on the market, wholly created in a laboratory and not derived from any plant. Reputable studies have shown, and the Centers for Disease Control and Prevention has found, that some synthetic cannabinoids can have deleterious health effects. And there are unscrupulous people who try to pass synthetic cannabinoids off as naturally derived. This is why I strongly believe in regulation. 

I am not suggesting that all synthetic cannabinoids should be characterized as Schedule 1 Narcotics, as the DEA has seemingly implied. But, we do need more research on synthetic cannabinoids and proper labeling so that consumers always know if they are buying naturally or synthetically derived cannabinoids.  

My opinion is that regulation and labeling standards are a better solution to this issue than outlawing and criminal prosecutions. For example, California recently became the first state in the nation to apply a “terroir” law to cannabis, stating that any marijuana grown in the “sun and soil” of certain California counties can carry an ‘appellation of origin’ labeling, similar to the practices of the wine industry. 

The new law “prohibits the name of a California county, including any similar name that is likely to mislead consumers as to the kind of cannabis contained in the product, from being used, as specified, unless 100 percent of the cannabis contained in the product was produced in that county.”

A verification process and labeling standard for synthetic vs. naturally derived cannabinoids, similar to California’s ‘appellation of origin’ legislation or to the food industry’s voluntary opt-in to the Non-GMO Project with its accompanying butterfly logo on labels, could go a long way towards providing much-needed clarity. It would also help consumers understand if they are buying products derived from real hemp, grown in soil, or hemp developed in a laboratory. 

The U.S. Hemp Authority certification program already prohibits the use of synthetic CBD by members and the HIA has recommended that the FDA ban the manufacture and marketing of synthetic CBD due to safety concerns. However, the industry as a whole has not yet adopted a clear labeling standard on this matter. As we wait for the United States District Court for the District of Columbia to hear the HIA’s case against the DEA and make a final decision on the new interim rule, it seems wise to begin working towards one.

Contextual Links

Filed Under: Compliance and Regulations, Hemp Policy & Legal, Lab Testing, Policy & Legal, Processors, Standards and Certification Tagged With: Centers for Disease Control and Prevention, Hemp Industries Association (HIA), Labeling, U.S. Drug Enforcement Administration (DEA)

About Henry Baskerville

Henry Baskerville is Managing Partner at Fortis Law Partners. He is an experienced trial lawyer who focuses on complex commercial litigation, white collar criminal defense, government contracts, construction law, and marijuana law.  Henry has received an AV Preeminent Rating from Martindale-Hubbell, the highest possible rating, for both legal ability and ethical standards. Henry has represented numerous individual and corporate clients in a wide variety of disputes, including breach of fiduciary duty, fraud, fraudulent transfers, alter ego, trade secrets, restrictive covenants, False Claims Act claims (qui tam cases), breach of contract, labor and employment disputes, securities, and bankruptcy and receivership proceedings. He has tried cases in courtrooms across the country and has handled appeals to the Fourth Circuit, Seventh Circuit, and Tenth Circuit Courts of Appeals. Henry frequently represents parties in disputes over ownership of closely held companies. For more information, contact [email protected].

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Scientist, Hemp - Scotts Miracle-Gro - Gervais, OR
  • Senior Account Executive (Marketing & PR) - Acceleration Community of Companies - Los Angeles, CA
  • Administrative Law Judge - Temporary Appointment - WA State: Office of Administrative Hearings - Multiple Locations Statewide, WA

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·